您的位置: 首页 > 农业专利 > 详情页

Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
专利权人:
Ludwig Institute for Cancer Research Ltd.
发明人:
Old, Llyod J.,Johns, Terrance Grant,Stockert, Elizabeth,Scott, Andrew Mark
申请号:
AU2008287335
公开号:
AU2008287335B2
申请日:
2008.08.14
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
The present invention relates to antibodies, particularly antibody 175, andfragments thereof or antibodies derived therefrom, which bind to the EGF receptor,particularly to amplified or overexpressed epidermal growth factor receptor(EGFR) and to the de2-7 EGFR truncation of the EGFR. These antibodies are usefulin the diagnosis and treatment of cancer. Recombinant or hybrid antibodies havingthe variable region heavy or light chain sequence(s) of antibody 175 are alsoprovided. The antibodies of the present invention may also be used in therapyin combination with chemotherapeutics or anti-cancer agents and/or with otherantibodies or fragments thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充